Paul Tudor Jones’s Impax Laboratories, Inc. IPXL Stock Holding History

Paul Tudor Jones’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-18,812	Closed	-$313K	–	1392
2017 Q4	$313K	Buy	18,812 +7,453	+66%	+$137K	0.01%	788
2017 Q3	$231K	Buy	+11,359	New	+$217K	0.01%	917
2017 Q2	–	Sell	-22,300	Closed	-$282K	–	1564
2017 Q1	$282K	Sell	22,300 -55,312	-71%	-$668K	0.01%	1044
2016 Q4	$1.03M	Buy	77,612 +61,382	+378%	+$1.05M	0.03%	360
2016 Q3	$385K	Sell	16,230 -36,178	-69%	-$972K	0.01%	869
2016 Q2	$1.51M	Buy	52,408 +24,205	+86%	+$789K	0.03%	296
2016 Q1	$903K	Buy	28,203 +6,240	+28%	+$219K	0.02%	568
2015 Q4	$939K	Buy	21,963 +9,663	+79%	+$386K	0.03%	488
2015 Q3	$433K	Buy	12,300 +3,300	+37%	+$149K	0.01%	859
2015 Q2	$413K	Sell	9,000 -300	-3%	-$14.2K	0.01%	892
2015 Q1	$436K	Sell	9,300 -29,750	-76%	-$1.18M	0.01%	810
2014 Q4	$1.24M	Buy	39,050 +2,197	+6%	+$64.3K	0.04%	257
2014 Q3	$874K	Buy	36,853 +18,853	+105%	+$483K	0.03%	358
2014 Q2	$540K	Hold	18,000	–	–	0.02%	494
2014 Q1	$476K	Buy	18,000 +6,900	+62%	+$172K	0.02%	557
2013 Q4	$279K	Buy	+11,100	New	+$248K	0.01%	927

Other funds holding IPXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Paul Tudor Jones's IPXL Position: Q1 2018 in Review

Paul Tudor Jones sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 18,812 shares — an estimated $313K sold.

Paul Tudor Jones first reported a position in IPXL in Q4 2013 and held it in 16 quarters. The position peaked at $1.51M in Q2 2016. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.

Paul Tudor Jones reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
Paul Tudor Jones sold 18,812 Impax Laboratories, Inc. shares in Q1 2018, an estimated $313K.
Paul Tudor Jones first reported a position in Impax Laboratories, Inc. in Q4 2013 and held it in 16 quarters.
Paul Tudor Jones's Impax Laboratories, Inc. position peaked at $1.51M in Q2 2016.
188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.

Based on Tudor Investment Corp's 13F filing for Q1 2018, filed 15 May 2018.